Trademark: 79206144
Word
DRAINAD
Status
Registered
Status Code
700
Status Date
Tuesday, February 27, 2018
Serial Number
79206144
Registration Number
5409575
Registration Date
Tuesday, February 27, 2018
Mark Type
4000
Filing Date
Friday, September 30, 2016
Published for Opposition
Tuesday, December 12, 2017

Trademark Owner History
Immungenetics AG - Original Registrant

Classifications
5 Biochemical and chemical preparations for medical purposes in particular those with the active ingredient thiethylperazine, for use in neurodegenerative diseases; biochemical and chemical preparations for medical purposes in particular those with the active ingredient thiethylperazine, for use in dementia disorders and their earlier stages, in particular for use in Alzheimer's disease and mild cognitive impairment; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for prevention against neurodegenerative diseases; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for preventing dementia disorders and their earlier stages, in particular for preventing Alzheimer's disease and mild cognitive impairment; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for the treatment of neurodegenerative diseases; biochemical and chemical preparations for medical purposes in oral administration forms, namely, pills, tablets, dragées, capsules, liquids, drops, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of neurodegenerative diseases; biochemical and chemical preparations for medical purposes in oral administration form, namely, pills, tablets, dragées, capsules, liquids, drops, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of Alzheimer's disease and mild cognitive impairment; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for the treatment of dementia disorders and their earlier stages, in particular for the treatment of Alzheimer's disease and mild cognitive impairment; biochemical and chemical preparations for medical purposes in parenteral administration form, namely, injection solutions and infusion solutions, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of neurodegenerative diseases; biochemical and chemical preparations for medical purposes in parenteral administration forms, namely, injection solutions and infusion solutions, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of Alzheimer's disease and mild cognitive impairment
1 Chemical products for the production of viral, retroviral and non-viral vectors
DRAIN AD

Trademark Events
Feb 27, 2023
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Mar 11, 2022
Change Of Name/Address Rec'd From Ib
Oct 20, 2021
New Representative At Ib Received
Jul 26, 2019
New Representative At Ib Received
Jun 29, 2018
Final Decision Transaction Processed By Ib
Jun 4, 2018
Final Disposition Notice Sent To Ib
Jun 4, 2018
Final Disposition Processed
May 27, 2018
Final Disposition Notice Created, To Be Sent To Ib
Feb 27, 2018
Registered-Principal Register
Feb 21, 2018
Teas Change Of Correspondence Received
Dec 12, 2017
Published For Opposition
Dec 8, 2017
Notification Processed By Ib
Nov 22, 2017
Notification Of Possible Opposition Sent To Ib
Nov 22, 2017
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Nov 22, 2017
Notice Of Publication
Nov 3, 2017
Approved For Pub - Principal Register
Oct 20, 2017
Teas/Email Correspondence Entered
Oct 20, 2017
Correspondence Received In Law Office
Oct 12, 2017
Assigned To Lie
Sep 29, 2017
Teas Response To Office Action Received
Jun 3, 2017
Refusal Processed By Ib
May 18, 2017
Non-Final Action Mailed - Refusal Sent To Ib
May 18, 2017
Refusal Processed By Mpu
May 10, 2017
Non-Final Action (Ib Refusal) Prepared For Review
May 9, 2017
Non-Final Action Written
May 6, 2017
Application Filing Receipt Mailed
May 2, 2017
Assigned To Examiner
May 2, 2017
New Application Office Supplied Data Entered
Apr 27, 2017
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24